Come and join us across the globe
In this interview from São Paulo, Tudor Jovin discusses with Igor Pagiola the future of treating medium vessel occlusions (MeVO) in acute stroke. He emphasises the need for refined patient selection, better endpoints, and new strategies, including device adaptation and revisiting thrombolytics. Drawing lessons from past trials, he advocates for continued research, highlighting that despite disappointing early results, MeVO remains a treatable condition with promising paths ahead.
